Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

FDA clears IND for ImmuLogic's cocaine vaccine

Dec. 5, 1997

Alza and SmithKline Beecham expand Nicoderm marketing agreement

Nov. 19, 1997

New chemical candidate for treating cocaine addiction

Nov. 3, 1997

Spotlight on smoking cessation therapy

Oct. 27, 1997

Nicotrol launched in Austria as OTC

Oct. 24, 1997

FDA clears generic transdermal nicotine product

Oct. 22, 1997

Therapeutic Antibodies and Altana enter alliance for emergency medicine products

Oct. 17, 1997

Orphan Medical licenses out European rights to Antizol

Sep. 23, 1997

Sano's combination patch shows promise for smoking cessation

Sep. 12, 1997

Guilford receives government contract for cocaine addiction research

Aug. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...